Pagenax Solution for Injection

Overview Pagenax Solution for Injection

Intravitreal Pagenax is indicated for adult patients with neovascular age-related macular degeneration. This medication inhibits vascular endothelial growth factor (VEGF), a protein responsible for abnormal ocular blood vessel proliferation, thereby slowing disease progression and potentially preserving vision. Administration is via intravitreal injection, exclusively by a qualified ophthalmologist or trained nurse; self-injection is strictly prohibited. Dosage and treatment frequency are individualized and prescribed by the physician; adherence to the prescribed regimen is crucial for optimal therapeutic outcomes. Common adverse effects include ocular pain, decreased visual acuity, blurred vision, vitreous floaters, retinal hemorrhage, and elevated intraocular pressure. Persistent or worsening side effects necessitate immediate medical consultation. Pagenax is contraindicated in individuals with known hypersensitivity to any constituent. Prior to initiating treatment, comprehensive disclosure of existing medical conditions, particularly ophthalmic surgery or pathology, is mandatory. Treatment should be deferred in the presence of any ocular infection.

Primary Ingredients of Pagenax Solution for Injection

No text provided to rephrase.

Uses of Pagenax Solution for Injection

Managing neovascular age-related macular degeneration

Major Benefits of Pagenax Solution for Injection:

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of Pagenax Solution for Injection:

• Retinal hemorrhage (bleeding)
• Uveitis
• Eye pain
• Reduced visual acuity
• Blurred vision
• Increased intraocular pressure
• Corneal abrasion
• Vitreous floaters
• Iridocyclitis
• Iritis (inflammation of the middle layer of the eye)
• Retinal vascular disease
• Vitreous haemorrhage
• Vitreous detachment
• Cataract
• Conjunctival hemorrhage
• Punctate keratitis

How to use Pagenax Solution for Injection:

Medical professionals will instruct you on the proper administration of this medication.

How Pagenax Solution for Injection works:

Abnormal blood vessel growth beneath the retina, stimulated by vascular endothelial growth factor (VEGF), underlies certain eye diseases. This process causes retinal fluid leakage, hemorrhage, and damage to the macula—the central visual area—resulting in blurred and distorted vision, potentially leading to significant sight impairment. Pagenax Injection neutralizes VEGF's activity, thereby curbing the formation and leakage of these aberrant retinal vessels.

What if you forget to take Pagenax Solution for Injection :

Omit a Pagenax injectable dose? Seek your physician's advice.